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Abstract Myotonic Dystrophy (DM) is a progressive multi-
systemic disorder characterized by myotonia and muscle
weakness where currently no effective treatment or cure to
prevent or delay the disorder exists. This study used mixed
methods to examine the experience of living with DM, in
patients and their close relatives. Thirteen patients and eight
next of kin responded completing Quality of Life and
Psychological distress questionnaires in this cross-sectional
study, and participating in a semi-structured interview. The
findings indicate a higher level of anxiety and hopelessness in
next of kin compared to patients, while patients were more
depressed. Next of kin reported higher physical, but lower
emotional quality of life than patients. Qualitative interviews
confirmed the questionnaire findings. The findings from this
study may be helpful in genetic counseling. Genetic coun-
selors and geneticists should not only be aware of the burden
of being a next of kin, but include discussions about opportu-
nities to minimize the burden in families affected with DM.
The findingsmay be of relevance in counseling for other types
of neuromuscular disorders.
Keywords Psychological distress . Quality of life .Myotonic
dystrophy . Next of kin .Mixedmethod . Genetic counseling
Introduction
Myotonic Dystrophy (DM) is an autosomal dominant, pro-
gressive neuromuscular disorder caused by mutations in chro-
mosome 19 (DM1) or more rarely chromosome 3 (DM2)
(Harper 2009; Schara and Schoser 2006). DM is the most
common adult form of hereditary dystrophic disorders, and
most of these patients have a DM1 mutation (Harper 2009;
Mankodi 2008). The main features of DM in general are
muscular weakness, atrophy and myotonia (Mankodi 2008;
Schara and Schoser 2006). Additional multisystem disorder
symptoms and signs include cataracts, endocrine, cardiovas-
cular and neurological abnormalities as well as affective
changes. Congenital onset and cognitive dysfunction have
only been reported in DM1 (Mankodi 2008). DM can present
at all ages, however the earlier the DM symptoms appear the
more multisystem involvement (Fokstuen et al. 2001).
The DM population has increased owing to improved
molecular genetic diagnosis as well as developments in treat-
ment. This has resulted in an increasing number of individuals
recognized with long-term health problems. In addition to the
health problems, social and psychological demands on the
family system can place burdens especially on the immediate
family members of persons afflicted by DM, as shown in a
study with three groups of muscular dystrophy (Boström and
Ahlström 2005a). Our own clinical experience shows that
everyday life in a family where one or more members affected
by DM1 is often characterized by changes in various routines
made necessary by the illness. The family’s ability to deal with
the challenges represented by this chronic condition and its
effects depend in great part on how family members are able
to perceive and integrate DM1 and its influence on their
everyday lives through processes of “normalization.”
Adulthood is normally characterized by high levels of
activity and productivity, involving processes of gaining edu-
cational credentials, starting careers, getting married, starting
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families, and preparing for and then retirement. However,
these normal life processes, including goals and dreams,
may become complicated when a chronic disability like
DM1 affects one or more family members. The resulting
challenges to physical, mental and cognitive functioning
may vary, as well as feelings of fatigue, powerlessness and
psychosocial consequences (Mankodi 2008). Since DM is a
dominantly inherited disorder, on average, one of the parents
of the DM affected individual as well as half of her/his siblings
and own children are affected by the illness, and impaired
functions may affect and be shared with other family members
(Hilton-Jones 1997). Increased severity compared to previous
generations characterizes DM, in contrast to most other auto-
somal dominant disorders. Anticipation is almost exclusively
maternal. Increasing disability among individuals with DM
has been shown to be associated with increased dependency
(Nätterlund et al. 2000), and it is documented that the persons
affected by DM view the future in terms of the need for more
help (Boström and Ahlström 2004). However, many DM
affected individuals concentrate on “day to day” functioning
and avoid thinking about the future and its demands (Boström
and Ahlström 2004).
During the past decade, studies have been published indi-
cating that Quality of life (QoL) in patients with different
dystrophic muscular disorders is associated with age of onset,
civil status and having children (Boström and Ahlström
2005b), severity and duration of the illness as well as specific
emotional functioning (Boström and Ahlström 2005b; Peric
et al. 2010). Other aspects of physical functioning, such as
gastrointestinal symptoms, have been shown to impact nega-
tively on one’s QoL (Rönnblom et al. 2002) together with
sleep problems (Culebras 2005; Dhand and Dhand 2006).
Increased need for help is associated with DM patients’
feelings of reduced levels of well-being and higher levels
of anxiety and depression (Timman et al. 2010). Compared
to healthy relatives and controls, adults with DM are found
to have lower scores on QoL (Antonini et al. 2006; Boström
and Ahlström 2005b; Kalkman et al. 2005). According to
Antonini et al. (2006) personality changes, affective symp-
toms, and cognitive and emotional deficits, also appear to
impact negatively on QoL in DM1 patients.
Depressive or anxiety symptoms, however, have not been
found more frequently in the DM group compared either to
patients with facioscapulohumeral dystrophy or to healthy
controls. On the other hand DM affected individuals score
higher in relation to emotional deficits (i.e. monotonous mood
states, apathy, and inability to anticipate pleasure) (Bungener
et al. 1998).
Among partners/spouses of DM patients lower levels of
well-being and higher levels of anxiety were found to be
associated with lack of initiative from the patients as well
as reduced marital satisfaction (Timman et al. 2010). Next
of kin of the affected individual, including partners, parents,
children, siblings and more distant relatives experience poorer
QoL in comparison to persons living without such burdens
(Boström and Ahlström 2005b). On the other hand, in a
qualitative study of the next of kin who had two or more
relatives (called “double kin”) affected with neurofibromato-
sis type 1, these individuals reported that, despite their expe-
rienced health burden, they saw themselves as healthy and
with overall good QoL (Hoxmark 2010).
The main thrust of the research literature thus far supports
the notion that being affected with DM gives rise to numerous
illness-related problems in everyday life and that individuals
affected by this disorder typically face a range of serious
challenges to psychosocial functioning including coping,
mental health and lower QoL. Less focus has been given the
next of kin to the DM affected person.
Most of the studies described above identified their patient
group as DM in general and did not distinguish between DM1
and DM2. Myotonic dystrophy type 1 (DM1) and type 2
(DM2) share many of the same clinical features which may
be the reason for the lack of distinction. However, DM1 and
DM2 have key differences. DM1 is the only form with
known cognitive dysfunction and congenital onset, and the
multi-systemic effects are typically more burdensome than
the muscle weakness. This aspect may lead to occupational
and psychosocial limitations affecting coping, management,
psychosocial health and quality of life, as emphasized by
Mankodi (2008).
Our study focused on the DM1 group. The purpose of this
study was to use mixed method (i.e., both qualitative and
quantitative methods) to describe the burden of being a next
of kin compared to the affected individuals, including their
psychological distress and quality of life. The research ques-
tions were: 1) How do patients and next of kin to patients with
DM1 experience their burden? 2) Do next of kin and the
person with DM1 have a similar experience of quality of life
and psychological distress? 3) Is there a correlation between
experienced QoL and psychological distress? and 4) Is the
experienced burden higher in next of kin compared to their
affected family member? For genetic counselors and geneti-
cists who meet families affected with DM1, the findings
should be of interest and useful.
Methods
Design
Our study used a mixed method design. The quantitative
component allowed for an examination of possible correla-
tions between QoL and psychological distress and for com-
parisons between next of kin and patients with DM1. The
qualitative component was characterized by in-depth inter-
views about these issues.
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Participants
Thirty-two individuals with a clinical diagnosis of DM1 con-
firmed by genetic testing were invited to participate in the
study. All were out-patients in different stages of the disorder
at the Centre of Congenital Neuromuscular Disorders at Oslo
University Hospital/Rikshospitalet. They were invited to in-
clude a relative or next of kin who they regarded as important
or influential in their lives. Both patients and their identified
next of kin were recruited via letters to the patients asking
them to inform their relatives or next of kin, about the re-
search. All participants, both patients and their next of kin,
signed documents of informed consent. Ethical approval for
the study was obtained from the Regional Committees for
Medical and Health Research Ethics (REC).
When performing a qualitative study, it is customary to use
strategic or purposeful sampling methods to obtain partici-
pants who are able to provide rich information (Kvale and
Brinkmann 2009; Patton 2002). Due to the relatively small
number of the total DM population at the Centre all were
invited to participate both in the quantitative and qualitative
parts of the study, and thereby ensure as comprehensive and
rich information as possible.
Measures
Demographic questionnaire. Demographic and DM1-related
information were collected in both groups, including back-
ground information about age, level of education, civil status
and working-life status, as well as DM1-related issues such as
duration of symptoms, years since the diagnosis, and level of
disabilities.
Quantitative questionnaires. To examine Quality of life
(QoL) and psychological distress, self-report questionnaires
were used. These include overall quality of life (OQoL), well-
being (WB), and health-related quality of life (HRQoL) ques-
tionnaires, as well as questionnaires measuring psychological
distress. Cantril’s (1965) Self-Anchoring Ladder (CL) and
Kaasa’s (Kaasa et al. 1988) test (KT) measured OQoL and
WB, respectively, while the Short Form 36 (SF-36) (Ware
et al. 1996a) assessed HRQoL.
The Cantril’s Ladder (CL) is an overall quality of life
questionnaire consisting of one question, “How is your life?”
asking respondents to rate their present satisfaction with life
on a scale anchored by their own identified values. The
response alternatives are 0–10 (0=worst possible quality of
life, 5=half-way between worst and best, 10=best possible
quality of life) (Cantril 1965). The CL has been shown to have
with high validity and reliability (Kolstad 1996).
The Kaasas Test (KT) assesses an individual’s psychoso-
cial experience of well-being (WB), and consists of ten items,
five positive and five negative statements (Rating scale:
1=highest WB to 5=lowest WB) (Kaasa et al. 1988).
The Health Related Quality of Life (HRQoL) measure
Short Form 36 (SF-36) (Ware et al. 1996a) is a questionnaire
assessing eight dimensions: physical functioning (PF), role
limitation due to physical health problems (RP), bodily pain
(BP), general health (GH), vitality (energy/fatigue) (VT), so-
cial functioning (SF), role limitations due to emotional prob-
lems (RE), and mental health (defined as psychological
distress and psychological well-being) (MH). The Physical
component scale (PCS) is based on the Physical Functioning,
Role limitation due to physical health problems, Bodily Pain,
and General Health, while theMental component scale (MCS)
involves Vitality, Social Functioning, Role limitations due to
emotional problems, and Mental Health dimensions. The SF-
36 has been extensively validated (Ware et al. 1996b).
According to a standard SF-36 scoring, all information is
transformed into a scale ranging from 0 (worst) to 100 (best).
Based on T-transformations, both PCS and MCS have a mean
of 50 and a standard deviation of 10 in the US general
population. This is also the case in other populations, including
the Norwegian population (Gandek et al. 1998). In these, cases
(i.e. severe quality of life below cut-off point that should be
considered as determinant of service and treatment) is defined
by a score <40 on both the PCS and the MCS (Gandek and
Ware 1998; Ware 1996; Ware et al. 1996b).
Psychological distress was examined using The Hospital
Anxiety and Depression Scale (HADS) (Zigmond and Snaith
1983) and Beck hopelessness scale (BHS) (Beck et al. 1974).
The Hospital Anxiety and Depression Scale (HADS) mea-
sures self-reported levels of distress (Bjelland et al. 2002) and
consists of 14 items with two subscales, anxiety (HADS-A)
and depression (HADS-D): each of these subscales has seven
items rated on 4-point Likert-style scale (0=not present, to
3=maximally present). The summed score on both the
HADS-A and the HADS-D ranges from 0 to 21. Cases
of HADS-defined possible anxiety and depression disorder
was set at a cut-off score ≥8 based on research findings
(Bjelland et al. 2002; Olsson et al. 2005). The psychomet-
ric properties of the Norwegian version of the HADS have
been found to be excellent (Mykletun et al. 2001).
The Beck Hopelessness Scale (BHS) (Beck et al. 1974) is a
20 item questionnaire designed to measure the degree of
hopelessness with item score options of 0 or 1. The BHS
summed score ranges from 0 to 20, and the lower the score,
the more optimism reported by the respondent. Scores from 9
to 13 indicate moderate hopelessness, while scores of 14 or
more imply severe hopelessness.
Qualitative interviews. A semi-structured interview, with
an interview-guide, was used to ask patients and next of kin
about experiences living with DM1 and how it impacted their
mental health and quality of life. The questions explored
functioning and physical activities, relation to work, family,
network and social life, plans and experienced changes.
Further, participants were asked about the experience of the
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burden of the disorder, and for comparison they were asked
what they also thought about the other’s (next of kin and
patient, respectively) experience. The questions were based
on experience from clinical experience as well as former
research. All interviews were carried out at the Centre of
Congenital Neuromuscular Disease at Oslo University
Hospital/Rikshospitalet, and lasted an average of 60 min for
both groups. All identifying information was removed when
the interviews were transcribed.
Data Analyses
SPSS version 18 was used for data handling and statistical
analyses. Tests for normal distribution were explored using
the Shapiro-Wilk Test. The Shapiro-Wilk Test is appropriate
for small sample sizes (<50 samples). A significance value of
the Shapiro-Wilk Test>0.05 indicates that the data are nor-
mally distributed. Descriptive statistics were calculated for
responses to the demographic questionnaire. All items except
the PCS component score were “normally distributed,” and
parametric tests were used to compare mean-scores between
groups with significance level set at p<0.05. In addition,
non-parametric statistic (Mann Whitney U-tests) were
employed, due to small samples, without different results.
Associations between QoL and psychological distress were
measured by bivariate correlations, two sided with signifi-
cance level set at p<0.01 and using Spearman’s rho due to
the small sample size.
Results
Response Rates
Fourteen of the 32 patients with DM1 invited to participate in
the study agreed to participate, giving a response rate of 44 %.
These patients were from nine unrelated families, each
consisting of from 1 to 4 members. One patient, however,
later withdrew from the study so a total of 13 outpatients
(41 %) (6 males and 7 females) took part in the study. In
comparison, the group of nonparticipants consisted of 12
males and seven females. Two individuals did not identify
next of kin, four relatives brought one common next of kin,
and each of the remaining patients included one next of kin,
whomostly were spouses, but also one child, one child-in-law,
or one parent. All together eight healthy relatives or next of
kin without risk for DM1 and 13 affected individuals were
included in the study. For some of the patients, it was possible
to obtain three generational family histories including affected
family members. However, for most of the patients, it was
possible to identify affected family members in only two
generational family histories.
Demographics and Disorder-Related Variables
The patients were aged between 18 and 61 years of age (mean
=40.9; SD=14.4). The mean duration since diagnosis was
10.7 years (SD=9.3) with a range from 1 to 30 years. Four
of the respondents (31 %) had university level educations. In
comparison, the group of nonparticipants was aged between
18 and 65 years (mean=42.4; SD=11.7), the duration since
diagnosis was 9.1 years (SD=6.2) (range: 3–26 years) with no
significant differences between the responders and non-re-
sponders. Five participants (40 %) were either employed or
in school; the others were on disability leaves or had disability
benefits. Four (31 %) reported movement inhibition (i.e.,
reduced mobility), and 4 (31 %) indicated heart problems
as their biggest problems, while the remainder described a
combination of these two factors as their biggest problem.
One respondent was wheelchair bound (i.e., used an assis-
tive device in daily activities), while seven patients (54 %)
perceived themselves as slightly disabled (Table 1). As long
as the non-participants did not respond to the invitation we
could not measure and compare demographic and disorder
related variables other than age and duration since diagnosis.
QoL Measures
Compared to their next of kin, the DM1 group reported
significantly lower levels on the SF-36 dimensions of physical
functioning (PF), general health (GH) and vitality (VT), as
well as the component scores for PCS and poorer well-being.
Nearly 62 % of the patients reported levels of PCS<40,
corresponding to very poor Health Related Quality of Life.
The prevalence of poor PCS was 12.5 % in the next of kin.
These results are detailed in Table 2.
There were no significant differences in reported levels of
overall QoL for patients versus their next of kin (see Table 2).
Psychological Distress
There were no statistically significant differences in anxiety,
depression or hopelessness for the two groups (see Table 3).
Associations Between Psychological Distress and QoL
As shown in Table 4, levels of anxiety and depression were
significantly and negatively correlated with overall QoL and
well-being in the patient group. Thus, as anxiety and depres-
sion increased, overall Qol and well-being tended to decrease
for patients. Levels of hopelessness were also significantly
and negatively related to well-being for patients. In the next of
kin group anxiety and hopelessness were negatively related to
well-being, level of depression was negatively associated with
overall QoL, well-being, and health-related Qol. All signifi-
cance levels were at <0.01 (Table 4).
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Qualitative Analysis Results
Both patients and next of kin reported that DM1 had a high
impact on daily life due to physical changes, ability and desire
to participate in different activities such as work and social
life, difficulties in planning, and changed relations and
roles in the family. In the analysis the researchers identi-
fied three major themes related to psychological distress
and experienced quality of life when being in a family charac-
terized by DM1: Expectations about life, Misunderstandings,
and a feeling of being on a “Roller Coaster.”
Theme 1: Expectations About Life
The most common themes due to psychological distress and
reduced quality of life were related to the gap between expec-
tations about life and the reality. For all participants, life had
been different than expected with changed plans and current
life situations. These differences included for some of the
patients, as well as next of kin: not having children, and for
those having children reduced ability to follow up the children
in their activities; reduced travel or having to quit traveling
altogether; social isolation to different degrees; and reduced
working ability or being forced to terminate employment.
Every participant commented on the differences between
Table 1 Demographics in both groups and disorder related variables in
patients
DM patients (n=13) Next of kin (n=8)
Age
Mean (SD) 40.9 (14.4) 41.8 (9.4)
Range 18–61 24–55
Females (n/%) 7 (54) 5 (71)
Educational level (n/%)
≤High school 9 (69) 4 (50)
≥College/university 4 (31) 4 (50)
Work participation (n/%)
Employee 5 (38) 7 (88)
Disability benefits 7 (60) 1 (12)
Years since diagnosis
Mean (SD) 10.7 (SD 9.3)
Range 1–30
Effect of disorder in daily life (n/%)
Some 3 (24) 5 (63)
Much 5 (38) 2 (25)
Very much 5 (38) 1 (12)
Compare own situation with other (n/%)
Never 4 (50)
Seldom 6 (45)
Often 3 (24) 4 (50)
Very often 4 (31)
Biggest problem (n/%)
Movement inhibition 4 (31)
Heart problems 4 (31)
Both 5 (38)
Depending of wheelchair (n/%)
Yes 1 (7)
No 12 (93)
Perception of own illness
Bad 11 (85)
Good 2 (15)
Own perception of disability (n/%)
Small? 7 (54)
No 6 (45)
Table 2 Mean and cut-off scores in Quality of Life and well-being in
patients and next of kin
DM patients DM next of kin P
n=13 n=8
Quality of life measures
Health related QoL
SF36
Physical functioning 52.30 (24. 80) 81.42 (34.84) 0.04
Role physical 59.62 (43.94) 53.57 (44.32) 0.77
Bodily pain 57.15 (22.24) 70.00 (32.98) 0.31
General health 35.54 (16.60) 71.17 (24.11) 0.001
Vitality 30.77 (16.31) 54.29 (29.22) 0.03
Social functioning 84.61 (19.87) 82.81 (29.08) 0.86
Role emotional 30.77 (41.86) 29.17 (45.21) 0.94
Mental health 74.77 (13.00) 73.71 (18.98) 0.89
PCS 37.29 (7.6) 48.02 (10.30) 0.02
PCS cases (n/%) 8 (61.5) 1 (12.5) 0.04
MCS 47.67 (6.74) 44.18 (13.57) 0.44
MCS cases (n/%) 2 (15) 2 (25) 0.50
Overall QoL
Cantril’s ladder 5.85 (2.30) 7.38 (1.92) 0.12
Experience of well-being
Kaasa’s test 2.77 (0.72) 2.05 (0.82) 0.05
Table 3 Mean and cut-off scores in psychological distress in patients and
next of kin
DM patients DM next of kin P
n=13 n=8
Psychological distress measures
HADS-A 5.15 (4.12) 7.75 (4.02) 0.17
HADS-A cases (n/%) 4 (31) 4 (50) 0.40
HADS-D 5.00 (2.80) 3.88 (4.49) 0.49
HADS-D cases (n/%) 2 (15) 2 (25) 0.61
BHS 12.38 (3.62) 15.13 (4.05) 0.23
BHS cases (n/%) 10 (77) 7 (85) 0.55
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their earlier expectations and the reality of their actual
lives. Examples from the patients are: “I would love to
have kids, and we had decided to have two, but due to
the disorder we will have none. I feel guilty for [letting
down] my spouse”; “Thoughts and plans are changed”;
“My wishes and expectations crumbled”; “I do not fear
the future, but I can feel depressed because of the
situation”; and “The reduced social relations are worse
for my spouse than me.”
Equivalent examples from the next of kin include:
“Because my spouse can’t help and share daily activities, all
the daily burdens are on my shoulders”; “We have become
isolated and lonely”; “We used to be social active, and expect-
ed this to continue, but people quit inviting us. Although we
have a sick family member, that does not mean that any of us
never can participate in social life”; “It is difficult for others to
understand, and it may seem impolite not to come after an
invitation, but we are never invited anymore”; “Because ev-
erything has to be planned very carefully, we can never do
anything spontaneous”; “I needed to quit my job due to all the
responsibilities in/for the family”; “Of course I am sorry we
can’t have children, but I have to understand”; “Life became
very different and harder, compared to what I expected”; and
“It is tough to be the person in charge all the time, we should
have shared the burdens.”
Theme 2: Misunderstandings
Almost all patients had an experience of being seen as un-
committed, not to mention lazy. Patients described common
and recurrent situations where they wanted to participate, but
could not afford to participate as wanted in social life, family
activities or work. This was often perceived as lacking will
and laziness. Examples include: “I am often misunderstood as,
I am seen as uninterested and lazy”; “I have to fight all the
time and I try to do small things, but I am not believed [when I
say] that I am not able to perform these tasks anymore. It is
hard”; “The diagnosis gave an answer, it was not only [my]
lack of will or laziness”; and “Even [though I] now have a
diagnosis, I very often hear I am lazy.” Common for the
patients were feelings of sadness and hopelessness due to
these misperceptions.
The next of kin’s perceptions can be characterized through
the following examples: “He is always tired and without
initiative. It is difficult. I am sure that even if he could
participate he does not bother”; “I do not really know if he is
as tired as he always says”; “Earlier he took responsibilities for
the children, but these days, everything is up to me”; “He is
doing very little, and when he is doing something, it is because
I have told him [to do it]”; and “I can’t be angry, but I do not
look into the future without [a] kind of anxiety.”
Theme 3: “Roller-Coaster”
Patients described their situation as being on a “Roller-coast-
er,” meaning life goes up and down. Life goes up in the sense
that they feel they have the energy, and down when they feel
they cannot meet expectations and desires, tasks and chal-
lenges, and despair over this. The feeling is described in the
following quotes: “It is like a roller-coaster, some days I am as
in older days, the next I am not able to do anything, and then I
can feel depressed”; “I have always felt I have been different,
but some days are better than other”; “It is so unpredictable, it
is mostly down, but also slightly up”; and “The ups and downs
do not increase my fear for the future, but I can sometimes feel
depressed.” Next of kin, also, expressed feelings of gladness
and joy when something works well, but they were very
realistic and described the situationmost of the time as “down-
hill.” The fact that the patients’ condition is progressive and
that there at the same time are bright spots in their existence,
contribute to the next of kin’s feeling of being on a roller
coaster, as well: “On the good days we make plans, but very
often they do not come to pass. So, really, we can never plan a
thing, everything depends on how it is today”; “It is tiresome
Table 4 Significant correlations between psychological distress and Quality of Life in patients and next of kin
Psychological distress measures
HADS BHS HADS BHS
Anxiety Depression Hopelessness Anxiety Depression Hopelessness
Patients (n=13) Next of kin (n=8)
Quality of life measures Cantril’s Ladder −0.707 −0.619 −0.923
SF36 PCS
Component scales MCS −0.658
Kaasa’s test Well-being −0.720 −0.723 −0.658 −0.902 −0.904 −0.804
All correlations were done two-sided with significant level set at p<0.01
Physical component scale (PCS), contributing on the basis of PF, RP, BP, and GH. Mental component scale (MCS), contributing VT, SF, RE, and MH
dimensions
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not to know how today or the next day will be”; and “I am not
depressed about the situation, really, but thinking of the future,
I have more anxiety.”
Mixed Method Analysis Results
Even there was no statistically differences between next of kin
and patients due to psychological distress measures, the com-
bination of quantitative and qualitative data analysis identified
that next of kin experience the situation as more hopeless and
have more anxiety for the future than patients, while patients
feel more depressed due to the current situation than next of kin.
When side-by-side comparisons of qualitative and quanti-
tative results were done, next of kin’s orally reported experi-
ence of hopelessness is contiguous with the results from
Becks Hopelessness Scale (BHS) where higher score level
indicate more hopelessness; moreover, individuals with scores
greater than 14 may be experiencing severe hopelessness. The
BHS conceptualizes positive (optimism) or negative
(hopelessness) expectations about one’s short- and long-term
future (Beck et al. 1974). It is the latter that was prominent in
the next of kin’s comments. In the patients, on the other hand,
it seems that their expectations, both according to the short-
and long-term future are slightly more positive.
The next of kin also reported a tendency to more anxiety, in
interviews as well as in the self-reported questionnaires com-
pared to the patients. Anxiety, as measured by the Hospital
Anxiety and Depression scale (HADS) can be seen as a
response to a threat (Zigmond and Snaith 1983); in this case
a threat of worsening health due to DM1. A vigilant attention
to threatening cues is an essential feature of anxiety, this
vigilance was seen among the next of kin to a higher degree
than among the patients themselves.
Depression is a concept with several meanings, but as
measured by the HADS it assesses clinical symptoms due to
mild mood disorder, mainly including loss of pleasure re-
sponse (anhedonia) (Zigmond and Snaith 1983). The patients’
tendency to higher score on HADS than next of kin is consis-
tent with their interview responses according to the three main
themes: Expectations about life, Misunderstanding, and The
feeling of life as a Roller Coaster.
The relationship between psychological distress and qual-
ity of life was emphasized as important of both next of kin and
the patients, which is consistent with the findings when mea-
suring the association between psychological distress and
quality of life with the self-report questionnaires.
Discussion
The findings indicated that next of kin have better physical
Health Related Quality of Life (HRQoL) and well-being than
patients with DM1. In the mixed method analysis the findings
between the quantitative and qualitative parts of the study
were consistent, as well as affirmativing possible differences.
The next of kin had a tendency to report more anxiety and
hopelessness, poorer mental HRQoL and less depression than
patients, although these differences were not statistically sig-
nificant. In the qualitative part of the study, however, differ-
ences and the tendency of there being differences were em-
phasized. Several associations between Quality of Life mea-
sures and psychological distress were found in both next of
kin and patients.
What is new in this study is the finding that the burden due
to psychological distress of DM1 seems to be more prominent
in next of kin than among the patients themselves. This might
point to a heavy burden of care for relatives, both in physical,
but particularly in mental health respects. In this study a
qualitative interview, as well as self-rated questionnaires were
used to explore and measure psychological distress, quality of
life and well-being. In addition to the interview, anxiety and
depression were measured with the self-rated Hospital
Anxiety and Depression Scale (HADS) where the anxiety
subscale focused on worry, tension and restlessness
(Bjelland et al. 2002). A HADS-defined anxiety disorder is
found to be highly correlated with self-rated diagnosis of
generalized anxiety disorder. This is characterized by exces-
sive and uncontrollable worry (APA 1994), which is closely
related to intolerance of uncertainty (Dugas et al. 2004).
The expressed level of anxiety measured with HADS
found in the next of kin may be understood as reflecting the
high levels of uncertainty they face in dealing with questions
about what will happen with their affected family member as
well as the future situations of their families. Because anxiety
is a response to threat, increased anxiety in the next of kin can
indicate perception of the threat, and can be understood as a
natural psychological response. Yet, anxiety can also be seen
as a healthy response to avoid a coming danger. The finding
that the patients tendency to emphasize anxiety less than their
next of kin might possibly indicate that DM1-affected indi-
viduals worry less about the progressive nature of the disorder
and the uncertainty of their future than do their healthy next of
kin. This may also be explained by the findings of Timman
et al. (2010) which concluded that the higher level of anxiety
in partners and spouses was, among other factors like marital
satisfaction, associated with lack of initiative from the patient.
The findings might be connected with a possible sample
bias given that the 13 patients who responded may have
higher functioning than those who declined participation
and thereby scored “better” than expected on the surveys
and interviews, as well.
Physical illness can cause depression over what is lost
according to the discrepancy between expectations regarding
life and the reality of life. The patients expressed this fact,
which in addition to their feelings of being misunderstood and
being on a roller-coaster, may explain why they feel
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depressed. Even next of kin also had similar feelings, although
according to the main themes of the interviews, their feelings
often had other expressions. They are not trapped in their own
bodies and diagnosis, and depressed by that, but often their
depression may come from their cognitions, in particular
thinking about the reality of their situation. This might explain
the expressed differences in mood between next of kin and
patients.
Hopelessness was, in addition to being explored in the
interview, measured with the self-rated Beck Hopelessness
Scale (BHS) (Beck et al. 1974), for which a higher level of
hopelessness indicates more negative expectations about
short- and long-term futures (Beck et al. 1974). A realistic
future perspective for individuals having a DM1 diagnosis
include that the situation will worsen physically, also include
a decline in mental/cognitive functioning. With this as a
background it is understandable that the next of kin reported
hopelessness. Their responses likely confirm the major chal-
lenge they experience, that is, living as a healthy spouse or
close relative in a family affected by DM1; their responses
also indicate a more realistic picture of how the future might
turn out. In light of these findings, it seems that the next of kin
are aware of and possibly understand the situation better than
the patient.
The findings that elevated psychological distress are asso-
ciated with, and affect quality of life (Qol) and well-being, are
consistent with the authors’ clinical experience. On the other
hand, living together with a partner has been found to be a
buffer against reduced mental health related QoL in other
groups living with hereditary disease (Geirdal et al. 2006).
For the DM1 patient this might be the case. For the healthy
next of kin, however, their partners or close relatives are
affected with DM1, and it seems that having an affected
partner may not be a buffer against poor mental health related
QoL, rather it increases the burden.
It is evident that DM1 affects the whole family, not
only the patient. However, it seems that next of kin and
patient experience the situation differently due to psycho-
logical distress and quality of life. To conclude: The
finding that it seems to be a heavier burden to be the
next of kin than the patient, depends probably on one’s
position in the family. However, it is obvious that next of
kin think ahead and see the whole family-situation in a
different light than the patients, which might cause distress
to a somehow higher level. Our study adds evidence to
other findings that being a next of kin appears to carry a
greater emotional burden, whereas being affected with
DM1 has a greater physical burden.
The results show executive function-limitations of individ-
uals affected with DM1 and indicate how this affects both the
affected persons and their next of kin. Several of the problems
identified in this study reflect common symptoms of the
disorder, and could be treated to provide ways for both patient
and caregiver to achieve better mental health, quality of life
and coping skills. Such treatments could include stimulants
for fatigue, and physical therapy to employ for energy con-
servation and pain management. In addition to understanding
the executive issues and individually addressing them with
professionals, treatment in groups would be an intervention
with great potential for better psychosocial health. Addressing
common problems, challenges and solutions in groups led by
professionals, as well as self-help groups, have been shown to
be of great importance for the participants (Geirdal 2007;
Heap 2005). Extended help in the home primarily in order to
relieve necessary everyday tasks where close relatives are a
spouse or children, freeing up time for all the family members,
as well as informational meetings could be another potential
intervention with beneficial outcomes. Individual invited to
such information meetings would include the DM1 affected
individual, and their next of kin, in addition to persons they
wanted to invite. The main objective could be to learn more
about the disease with the goal of reducing misunderstandings
and the feelings of being on a roller-coaster.
Study Strengths and Limitations
We used established and validated self-report measures in
addition to qualitative interviews. This mixed methods ap-
proach may be seen as a strength of the study. All individuals
with DM1 known at Oslo University Hospital, Rikshospitalet
received invitations to participate in the study together with
their next of kin. However, only 44 % accepted the invitation,
but one withdrew, so a total of 41 % were included in the
mixed method analysis. The high number of dropouts possi-
bly may be attributed to different reasons. Some examples are
experiencing oneself as “too sick” and not wanting to meet the
health care-team when they do not “need to,” that is, not
needing to participate in research projects. Non-participants
may feel generally ill, thus lacking the energy to participate or
travel; and they may generally be uninterested in participating
in a study which further identified them as “affected” which
might cause further depressive feelings; and they may prefer
to use whatever energy they have for their own prioritized
tasks. These reasons may explain the low participation rate
and the high number of dropouts. The low response rate
could also be understood as part of the burden of the
disorder’s costs to everyday life. One example of this
involves a single patient who withdrew from the study
before it was completed, explaining it was too tough to
participate due to poor general health conditions and problems
with concentration and persistence.
The study is a cross-sectional study, without the possibility
of giving an answer as to whether the results would have
changed over time. In addition given the small sample size,
the statistical analyses may have lacked sufficient power to
detect actual differences. A strength is however the mixed
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method design which showed consistent and confirming find-
ings between the quantitative and qualitative approaches.
Practice Implications
There is no effective treatment to prevent or delay DM1. In
genetic counseling it is important to be aware of the following
factors: DM1 is a disorder affecting the whole family, in
particular partners and close relatives in addition to the affect-
ed person. The situation includes increased anxiety and hope-
lessness in next of kin and increased depression in patients, as
well as reduced quality of life for both next of kin and patients.
The findings indicate that it is of importance to recognize this
element when the patient and next of kin come to the genetic
services or seek help in general. Further, the genetic counselor
and geneticist should not only be aware of the burden of being
a next of kin but also include discussions about opportunities
to minimize the burden in families affected with DM1. The
findings from this study might also be helpful when counsel-
ing other groups of neuromuscular disorders; the findings
could be translated to other genetic disorders that have a
similar neurodegenerative course.
Research Recommendations
Further research are necessary to explore actions and initia-
tives recommended herein, and how, and which, such initia-
tives can help reduce psychological distress and improve
quality of life in families affected with DM1. Studies could
be done that include samples from other clinics in Norway,
and even expanding to other Scandinavian and European
countries in an effort to increase the study population.
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